Ipamorelin
Never tested in a controlled trial for muscle, fat or sleep.
A five-amino-acid peptide that triggers a short pulse of . Its one drug program failed, and it is now sold mostly in a stack with CJC-1295. A , also called NNC 26-0161.
What the evidence shows
Side effects and risks
Who should avoid it: Athletes, and anyone with active cancer.
Athletes: Prohibited at all times (class S2). Named on the list as a growth-hormone secretagogue. USADA advisory on 2027 WADA list, 2026-10
How it works
- Where it acts
- Ghrelin receptors (growth-hormone secretagogue receptors) on the pituitary gland.
- What it changes
- A short pulse of growth hormone. In animals it barely raised cortisol or prolactin.
- What people notice
- Little human data. Hunger can increase.
How it has been given in studies
Into a vein in hospital, twice a day for up to a week. FDA says it has found no safety information for injected routes other than into a vein.
Getting it in the United States
The legal route for Ipamorelin
Not FDA-approved and not eligible for pharmacy compounding. Vials sold for research use only are unapproved drugs when marketed for people.
Routes people use for any peptide in the United States
Telehealth prescribing
Online clinics prescribe after a questionnaire, sometimes with no live doctor visit, and mail the drug. FDA moved in February 2026 to restrict mass-marketed compounded copies and claims that they are generic equivalents.
Risk: Thin medical screening. Compounded versions are not reviewed by FDA for quality.
Covers: Approved GLP-1 drugs, compounded semaglutide and tirzepatide
Source: GZERO Media, Apr 2026
Clinical trial enrolment
The only lawful way to get an unapproved peptide drug with medical monitoring. ClinicalTrials.gov lists eligibility, sites and phone numbers. Researchers note recruitment is hard when people can buy the drug on the gray market instead of risking placebo.
Risk: Possible placebo assignment, strict eligibility and travel to a study site.
Covers: Investigational peptide drugs still in development
Source: NIH, finding a clinical trial
Compounding pharmacy via clinics
FDA advisers voted against it and a final rule is pending. FDA says it lacks safety data for common injection routes, so pharmacy supply sits in legal limbo.
Online research-only vendors
Anti-doping officials note such peptides are sold as laboratory-use products not made to approved manufacturing standards. Athletes who use them face multi-year bans.
Source: USADA sanction notice, 2017-05
Routes people use for any peptide in the United States
Compounding pharmacy with prescription
A clinician prescribes and a pharmacy compounds. Twelve peptides left the FDA do-not-compound category in April 2026 and a panel backed six in July, but they are not yet formally eligible. Pharmaceutical-grade ingredient is scarce.
Risk: Legal status is unsettled until FDA rulemaking ends. Pharmacies may use research-grade ingredient.
Covers: BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon and similar
Source: Frier Levitt, Apr 2026
Med spas and weight-loss clinics
Very common. Secret shoppers called 75 clinics and med spas in two states after shortages ended. 92 percent offered compounded semaglutide and 87 percent tirzepatide, often mixed with B vitamins to look custom.
Risk: Four of 23 suppliers lacked sterile compounding licenses and four had disciplinary records.
Covers: Compounded semaglutide and tirzepatide
Source: American Med Spa Association on JAMA Health Forum study, Jul 2026
Concierge and longevity doctors
Cash-pay physicians build peptide plans for wealthy clients. Reporting from San Francisco says some source from overseas channels, domestic research-use-only sellers or the few compounding pharmacies that will supply clinicians.
Risk: A doctor's involvement does not guarantee a pharmaceutical-grade product.
Covers: BPC-157, thymosin alpha-1, Selank, Semax, CJC-1295, ipamorelin, retatrutide
Source: San Francisco Standard, Sep 2025
Cross-border purchase or import
FDA says importing drugs for personal use is illegal in most cases but it may not object to small personal quantities in limited situations. Reporting also describes people travelling to Mexico for injections.
Risk: Packages can be seized. Product origin and cold-chain handling are hard to check.
Covers: Approved prescription peptides sold abroad
Source: FDA, personal importation
Routes people use for any peptide in the United States
Research-chemical websites
Sites sell vials marked for research or not for human consumption, with no prescription. FDA says some ship direct to consumers with dosing directions, and it has sent warning letters. Retatrutide exists only through this route or trials.
Risk: Unknown identity, strength and sterility. No pharmacist or prescriber involved.
Covers: Retatrutide, semaglutide, tirzepatide, BPC-157 and most unapproved peptides
Source: FDA, unapproved GLP-1 drugs page
Direct orders from Chinese factories
Buyers message factory sales agents and pay by crypto or payment app. A minimum order of about ten vials pushes people to buy in bulk and share. A blockchain analysis found US buyers were the largest source of funds.
Risk: Many of the same vendors list fentanyl precursors. Lab reports sent by sellers cannot be verified.
Covers: GLP-1 copies, melanotan II, BPC-157, TB-500, GHK-Cu, epitalon
Source: TRM Labs, Oct 2026
Chat groups and social sellers
Dealers are found through Telegram, WhatsApp, Discord and influencer discount codes. In a May 2026 survey of 1,000 US users, 14.5 percent bought this way and three quarters asked an AI chatbot for dosing.
Risk: 45 percent of social media buyers in that survey reported an emergency or urgent care visit for a reaction.
Covers: Retatrutide and other research-use-only peptides
Source: The Ethos, May 2026
This describes what people do. It is not advice. The decision is yours.
What users report
Recurring themes in public forum posts, unverified and with no comparison group.
Reported benefits
- Better sleep
- Less hunger than the older GHRP peptides
Reported problems
- Head rush or headache after injecting
- Water retention
- Subtle at best
More contextCase reports, what public figures say, videos and articles, when options run out and the chemistry
Case reports
From journals, regulators and studies of users. One case proves little.
Harm reportednews-reported case - 1 person - 2026
A masters weightlifter tested positive for ipamorelin and another growth hormone booster at a world championship and accepted a three-year ban.
Source: USADA sanction notice, 2026-02
Harm reportednews-reported case - 1 person - 2017
A US track and field athlete admitted using ipamorelin and a related peptide from 2013. He received a four-year ban and lost results back to that year.
Source: USADA sanction notice, 2017-05
Serious events in intravenous ipamorelin study
Harm reportedcase series - 2023
The FDA cites a published study in which serious adverse events, including death, occurred when ipamorelin was given intravenously to improve gut motility. The agency says it has no safety information for some other injectable routes.
What experts and influencers say
Paraphrased from the linked sources.
Calls the craze unfounded. He found no randomized human trial showing the advertised benefits for any of the unapproved peptides he reviewed, and warns about stacking several at once. He points to animal work in which TB-500 sped up dormant tumor growth and to a theoretical cancer concern with growth-hormone peptides and BPC-157. He treats the GLP-1 drugs as the well-studied exception.
Source: Eric Topol, "The Peptide Craze", Jul 2025, Associated Press, Nov 2025
Eric TopolWebsiteWarns against
Devoted a full episode in 2024 to how these peptides are thought to work and how people use them. He presents possible benefits for healing, growth hormone, sleep and libido, and also says most of the data comes from animals, that black-market products may be contaminated, and that anyone with a tumor or cancer concern should avoid peptides that promote growth or new blood vessels.
Source: Huberman Lab episode, 1 Apr 2024
Described ipamorelin as acting through the hunger hormone pathway, said it can raise appetite and may cost REM sleep, and discouraged grey-market sources.
Andrew HubermanInstagramMixed view
Co-wrote a review of 565 studies on six peptides, including CJC-1295 and ipamorelin. Concluded proof of benefit is missing, safety is unknown and marketing has outrun the science, and advised waiting for rigorous trials.
Source: UCLA Health news, 2026-08
Thomas KremenWebsiteWarns against
Photo source: uclahealth.org
Wrote that moving ipamorelin back toward legal compounding restores a regulated route but does not prove it works. He advised against research-only web purchases.
Source: Pharmacy Times, 2026-06
Mohammed ChammoutWebsiteMixed view
Photo source: pharmacytimes.com
Keeps ipamorelin acetate flagged as a safety risk for compounding. It cites immune reaction risk from impurities and a published study with serious adverse events including death after intravenous use.
US Food and Drug AdministrationSourceWarns against
The NBA suspended him for 25 games after a test showed ipamorelin and GHRP-2. He denied ever using a banned drug and his lawyer said they would appeal.
Source: CBS Sports, 2018-04
Jodie MeeksInstagramMixed view
Wrote that ipamorelin's only sizeable human trial, in bowel recovery after surgery, showed no advantage over placebo, and that rat data showed weight and fat gain.
Source: Skeptic magazine, 2026-03
William MellerWebsiteWarns against
Photo source: skeptic.com
The NBA suspended him for 25 games without pay after he tested positive for ipamorelin.
Source: NBA.com, 2019-08
Wilson ChandlerInstagramMixed viewSays they used it
Sanctioned a masters weightlifter for three years in 2026 after a positive test for ipamorelin, and earlier banned a track athlete for four years for using it.
Source: USADA sanction notice, 2026-02
US Anti-Doping AgencySourceWarns against
Its advisory on the 2027 list says peptides are now named in the non-approved class. It lists BPC-157, TB-500, AOD-9604, GHRPs, ipamorelin and thymosin beta-4 and urges caution with any unnamed peptide.
Source: USADA athlete advisory, 2026-10
Told the public not to inject peptides bought online. Said unauthorized products are illegal, unproven and may cause organ damage, clots or tumour growth. A research-use-only label does not make them legal.
Source: Health Canada advisory, 2026-04
Health CanadaSourceWarns against
As an Enhanced Games recruit he listed testosterone, BPC-157, CJC-1295, ipamorelin and thymosin as substances he was using in 2025.
Source: Wikipedia, Enhanced Games, 2025
James MagnussenWebsiteRecommendsSays they used it
Money: Paid Enhanced Games competitor
Photo source: abc.net.au
Wrote that human evidence for BPC-157 amounts to three tiny reports. Called self-injection of online peptides high-risk, uncontrolled self-experimentation and asked for blinded placebo-controlled trials.
Stuart PhillipsWebsiteWarns against
Photo source: science.mcmaster.ca
Watch and read
Explainers, reporting and podcasts worth your time. Summaries are ours. No sellers.
The US is hooked on unregulated peptides. But are they effective, or even safe?
Bethany Brookshire, science journalist
Looks at influencer-driven use of self-injected peptides such as ipamorelin, the thin clinical evidence behind them, and how FDA rules may change.
Balanced look at what is known and unknown.
The Peptide Craze: Biohacking and Human Guinea Pigs
William Meller, MD
A physician argues that grey-market peptides including ipamorelin lack human evidence and carry risks such as contamination and immune reactions.
A doctor's pointed warning on safety and evidence.
What the peptide craze reveals about Americans' relationship with risk
Sarah Todd, STAT reporter
Essay on why unproven peptides appeal to Americans, citing a cardiologist's concern that growth hormone peptides like ipamorelin might raise cancer risk.
Raises the cancer-risk question many sellers skip.
How does the Peptide Ipamorelin Work?
Dr Rob Swanda, science educator
A science educator explains how the peptide ipamorelin is thought to work in the body, as part of a series on how peptides act.
Clear mechanism explainer on a non-seller channel.
When options run out
Uses people turn to when standard treatment has failed.
Bowel recovery after surgery
- Who
- Patients with stalled gut function after bowel resection, studied in hospital.
- Evidence
- One phase 2 trial of about 114 patients: intravenous ipamorelin was tolerated but did not significantly shorten the time to eating solid food compared with placebo. FDA advisers later reviewed this use and voted against compounding.
Legal last-resort routes
Expanded access (compassionate use)
For a serious or life-threatening condition with no comparable alternative and no trial you can join. Your physician asks the company for the drug, then files with FDA and an ethics board. The company can refuse. Costs are often not insured.
Right to Try
For a life-threatening condition after approved options are exhausted and no trial is open to you. The drug must have finished Phase 1 and be in active development. Your doctor asks the manufacturer directly. FDA does not review requests.
Source: FDA, Right to Try
Trial finders
Search ClinicalTrials.gov by condition or drug name, check eligibility and call the listed site. ResearchMatch is a free NIH-funded registry that lets researchers find you. Discuss risks with your own clinician before enrolling.
Source: NIH, finding a clinical trial
Personal import for serious conditions
FDA may not object when a US citizen imports up to about three months of a drug for a serious condition with no effective US treatment, with written personal-use confirmation and a US doctor's details. It is discretion, not a right.
Source: FDA, personal importation
Patient-specific compounding
When the approved product cannot meet a specific need of an identified patient, a prescriber can order a compounded version from a licensed pharmacy. Lower price alone does not qualify. Ingredients must be pharmaceutical grade.
Amino-acid sequence
Striped tiles are mirror-image (D) amino acids, which resist breakdown. Ringed tiles are amino acids not found in natural proteins.
Questions people ask
Does ipamorelin help with sleep?
Better sleep is a common marketing claim and a common user report, but no controlled trial has tested it. What has been shown, in small infusion studies in healthy men, is a brief rise in growth hormone.
Was ipamorelin ever developed as a drug?
Yes, for bowel recovery after surgery. In a 114-patient trial, time to the first tolerated meal was 25 hours against 33 on placebo, a difference that could be chance, and development stopped.
What are the side effects of ipamorelin?
Users report head rush or headache after injecting and water retention, and hunger can increase. FDA cites serious adverse events, including death, when it was given into a vein, and a risk of immune reactions to the peptide and its impurities.
Is ipamorelin legal?
In the US it is not on the list pharmacies may compound from and is on the FDA safety-risk list for outsourcing facilities. In Australia possession without authority is illegal, and Health Canada named it in a 2025 advisory.
Your notebook
Taking it? A ten-second daily check-in keeps a record of how you feel, to talk through with your clinician.
Sources
- Beck et al.: ipamorelin for postoperative ileus
- FDA: bulk substances that may present significant safety risks
- WADA Prohibited List
Structure: PubChem